Archive: 08/2012

Evidence-Based National Policies: Significance and Implications

Delivered at the 51st Regular Session of the Inter-American Durg Abuse Control Commission (CICAD) in 2012, this presentation explores the importance and relevance of evidence-based drug policy particularly: formulation, monitoring, and evaluation.  The presentation also examines how this policymaking method is more efficient than methods that do not utilize such evidence. The presentation condiders general principles of policymaking and explains how to apply those principles to a national drug policy, linking those principles to CICAD's policy framwork, which is compised of: Community, Strategy, Evaluation, and Budget. 

Download the PDF Presentation: "Evidence-Based National Policies: Significance and Implications"

Continue reading Evidence-Based National Policies: Significance and Implications


The Prescription Drug Epidemic: Current Trends and Policy Solutions

This 2012 presentation highlights current trends in prescription drug abuse and potential policy solutions. 

Major Topics Include:

Continue reading The Prescription Drug Epidemic: Current Trends and Policy Solutions


Using Prescription Drug Monitoring Programs to Inform Prevention Policy and Decision Making

Delivered at the National Prevention Network (NPN) Conference in Atlanta, GA on September 22, 2011, this presentation created for the Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Substance Abuse Prevention (CSAP) under the Data Analysis Coordination and Consolidation Center (DACCC) explores ways to use prescription drug monitoring programs (PDMPs) to inform substance abuse prevention policy and decision making.  

This presentation includes:

Continue reading Using Prescription Drug Monitoring Programs to Inform Prevention Policy and Decision Making


Prescription Drug Takeback Programs & Substance Abuse Policy

This Policy Brief examines prescription drug takeback programs in the context of substance abuse prevention.  Across America, drug takeback programs have become increasingly popular as policymakers struggle to provide individuals with a secure and convenient way to dispose of unused medications.  To learn more about takeback programs, Carnevale Associates, LLC surveyed a number of programs to better understand their design, costs, and efficacy to support national efforts to reduce the size and scope of the prescription drug epidemic.  Our analysis found that these programs vary substantially in cost and approach.   In addition, we found no evidence that takeback programs affect prescription drug abuse.  We conclude that additional research is needed before incorporating takebacks into any substance abuse prevention plan.

Downlaod the PDF: Prescription Drug Takeback Programs & Substance Abuse Policy

Continue reading Prescription Drug Takeback Programs & Substance Abuse Policy


The Federal Drug Budget Under Sequestration

With the failure of the Joint Select Committee on Deficit Reduction to reach an agreement, this Policy Brief examines the effects of a $1.2 trillion sequestration (automatic cut) on the federal drug control budget.  Slated for implementation beginning in 2013, Carnevale Associates' analysis finds that the proposed cuts would be much more detrimental to demand reduction programs than to supply reduction programs.  The disproportionate impact on demand reduction programs may impede the Obama administration’s stated aim of implementing the public health approach promoted in its National Drug Control Strategy. 

Download the PDF: The Federal Drug Control Budget Under Sequestration: Prevention Most Affected

Continue reading The Federal Drug Budget Under Sequestration



Sign Up For Our Newsletter


Contact Us

P.O. Box 84085 | Gaithersburg, MD 20883 Phone: 301.977.3600 | Email Us